MULTI-NATIONAL

MMG will effectively implement your patient recruitment and retention program no matter where in the world your patients are located.  Managing patient recruitment and retention for sites in North America, Latin America, Europe and Asia requires a specialized approach involving close contact with in-country teams and CRAs as well as careful management of ethics committee reviews. MMG knows which strategies work globally and will be accepted by ethics committees, and we will educate sites and CRAs to ensure that they implement your international recruitment campaign effectively.

The critical components we consider when conducting recruitment campaigns for global studies include:

• Acceptable tactics MMG keeps abreast of current permissible tactics and uses alternative means to achieve outcomes when necessary.
  
  
• Leveraged technology MMG's extranet portal, MMG ConneCT, ensures that all study partners in all countries have real-time access to information and tools for recruitment and retention activities.
  
  
• Work styles Site staff in certain countries prefer personal contact over e-mail or telephone communications for certain activities. MMG advises CRAs on cost-effective and best management practices for a variety of work styles.  Or MMG can direct its own personnel to support you on this front.
  
  
• Consensus building Collaboration between CROs, CRAs and MMG require delicate relationship building. MMG conducts face-to-face meetings prior to study kick-off with the CRO to get input and feedback on the recruitment strategy and tools. We provide rationale for recruitment materials, backed by facts and experience.
  
  
• Linguistic nuances MMG has a trusted network of certified, native-speaking translators to ensure that regional linguistic distinctions are represented in all required study materials.
  
  
• Realistic timelines Our corporate monitors are experienced in developing strategic plans to allow sufficient time for clients’ clinical and legal approvals, all IRB and ethics committee approvals, and to meet all privacy concerns.

Through our experience supporting global trials, we are able to recommend country-specific strategies and tactics to capitalize on individual protocol requirements.

INDICATIONS Breast cancer, Cancer-related anemia, CINV, Colorectal cancer, Head & neck cancer, Melanoma, Non-Hodgkin’s lymphoma, Non-small cell lung cancer, Prostate cancer vaccine, Prostate cancer, Oral mucositis, Pancreatic cancer, Peripheral sensory neuropathy, T-cell lymphoma, NCI intramural trials, Alzheimer’s disease, Anxiety, Bipolar disorder, More...
COUNTRIES Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Estonia, Finland, France, Georgia, Germany, Guatemala, Greece, Honduras, Hong Kong, Hungary, India, Ireland, Israel, Italy, Jamaica, Japan, Latvia, Lithuania, Mexico, Morocco, Netherlands, New Zealand, Norway, Peru, Philippines, Poland, More...	Gaynor Anders Vice President, European Operations Case studies Request a proposal